FDA reviews peptide injections favored by RFK Jr. and wellness influencers
Federal health regulators are convening a two-day meeting starting Thursday to scrutinize a handful of peptide compounds that have exploded in popularity among wellness enthusiasts, athletes, and high-profile figures like Health Secretary Robert F. Kennedy